首页 | 本学科首页   官方微博 | 高级检索  
     

三种钙磷陶瓷材料复合重组人骨形成蛋白-2体内成骨的研究
引用本文:龙厚清,李佛保,王迎军,廖威明,王会信. 三种钙磷陶瓷材料复合重组人骨形成蛋白-2体内成骨的研究[J]. 中国修复重建外科杂志, 2003, 17(3): 180-184
作者姓名:龙厚清  李佛保  王迎军  廖威明  王会信
作者单位:1. 中山大学附属第一医院骨科,广州,510080
2. 华南理工大学材料学院
3. 中国军事医学科学院
基金项目:国家自然科学基金资助项目 (59872 0 1 0 )~~
摘    要:
目的 探讨和比较3种钙磷陶瓷材料HA、TCP、HA/TCP复合重组入骨形成蛋白。2(rhBMP—2)体内异位成骨效果,为临床应用提供依据。方法 取35只3月龄Wistar大鼠,将复合rhBMP—2的3种钙磷陶瓷材料(1:1)植于鼠背部肌袋内,未复合rhBMP-2的上述3种单纯陶瓷材料为对照组。术后2、4和8周取材,测定植入物碱性磷酸酶(ALP)活性,通过HE染色和计算机图像分析进行组织学和组织计量学观察,比较新生骨组织的形成。结果 术后2、4周复合植入物ALP活性测定从高到低依次为HA、HA/TCP、TCP,但在相同rhBMP—2剂量下,其差异无统计学意义(P>0.05),与相对应单纯支架材料比较有统计学意义(P<0.05);组织学和组织计量学检测结果显示各复合材料组均有新骨形成,成骨量随时间推移而增加,2周时以HA/rhBMP—2成骨量较多,但3组间差异无统计学意义(P>0.05);8周时新骨形成以双相陶瓷HA/TCP最佳,相关参数和图像分析有统计学意义(P<0.05),成骨量8周较2、4周多,有统计学意义(P<0.01);3种单纯支架材料各观察期均无骨样组织形成。结论 双相陶瓷材料HA/TCP是携带rhBMP—2的钙磷陶瓷良好支架材料。

关 键 词:钙磷陶瓷材料 复合重组人骨形成蛋白-2 体内成骨 羟基磷灰石 磷酸三钙 双相钙磅陶瓷
修稿时间:2002-07-03

OSTEOGENIC POTENTIAL OF THREE KINDS OF CALCIUM PHOSPHATE CERAMICS AS CARRIERS FOR RECOMBINANT HUMAN MORPHOGENETIC PROTEIN-2 IN VIVO
LONG Hou-qing,LI Fo-bao,WANG Ying-jun,et al.. OSTEOGENIC POTENTIAL OF THREE KINDS OF CALCIUM PHOSPHATE CERAMICS AS CARRIERS FOR RECOMBINANT HUMAN MORPHOGENETIC PROTEIN-2 IN VIVO[J]. Chinese journal of reparative and reconstructive surgery, 2003, 17(3): 180-184
Authors:LONG Hou-qing  LI Fo-bao  WANG Ying-jun  et al.
Affiliation:Department of Orthopedics, First Affiliated Hospital, Sun Yat-sen University, Guangzhou Guangdong, P.R. China 510080.
Abstract:
Objective To investigate and compare the osteogenic potential of three kinds of calcium phosphate ceramic as carriers for recombinant human bone morphogenetic protein-2(rhBMP-2) in vivo. Methods BCP ceramics (HA,TCP,HA/TCP) impregnated with rhBMP-2 (experimental groups) and without rhBMP-2(control groups) were implanted into 6 muscles pockets on the dorsum of 3-month-old Wistar rabbits. The rabbits were sacrificed 2, 4 and 8 weeks after implantation and bone induction was estimated by alkaline phosphatase(ALP) activity measurement. The implants were also examined histologically and histomorphometrically by HE staining and computerized graphical analysis. Results The ALP activity of implants with rhBMP-2 was higher than that of control groups( P< 0.05), but there was no difference between 2 and 4 weeks in experimental groups. In all experimental groups,the implants exhibited that new bone formation increased with the lapse of time. The amount of new bone formation is more in HA/rhBMP-2 group than in the other two group in the 2nd and 4th weeks , but there was no difference between them (P>0 05). In the 8th week, the amount of bone formation was most in HA/TCP with rhBMP-2, and was more than that in the 2nd and 4th weeks. Whereas in control groups, there was only fibrous connective tissue. Conclusion HA/TCP is a good carriers of rhBMP-2 and can be used as bone substitutes clinically.
Keywords:Hydroxyapatite Tricalcium phosphate Hydroxyapatite/Tricalcium phosphate Recombinant human bone morphogenetic protein-2 Osteogenesis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号